A campaign push by some Republicans to make contraceptive drugs available without a prescription has some support from medical groups despite objections from women's health advocates. New York City ...

Corcept Therapeutics CORT has been making meaningful progress with its sole-marketed drug, Korlym (mifepristone), which is ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 10:30 AM ESTCompany ParticipantsRobert Duggan - Co-CEO ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM ESTCompany ParticipantsWilliam Meury - CEO, ...

Data presented at ASH suggested that CDK4/6 inhibitors given with chemo for Rb-deficient tumors could mitigate the risk of secondary myeloid neoplasms.

Deal marks Pfizer's re-entry into obesity treatment market Pfizer shares rise 1.4%, Novo Nordisk falls 1.3% Metsera candidate MET-097i advances to late-stage trials The greenlight from Metsera's ...

Signed, sealed and delivered, Metsera is finally Pfizer’s. Pfizer has completed its acquisition of the obesity biotech, capping a whirlwind two weeks in which rival pharma Novo Nordisk attempted to ...

Pfizer is a $145 billion pharmaceutical industry giant with a long history of success behind it. Wall Street bid the stock up during the COVID-19 pandemic, but now investors have soured on the shares.

Pfizer is buying out Metsera for up to $10 billion after an acquisition battle with another pharma giant. Metsera's leading candidate could be an excellent way for Pfizer to enter the weight-loss drug ...

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...

NEW YORK, November 13, 2025--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical ...

FRANKFURT, Nov 13 (Reuters) - BioNTech (22UAy.DE), opens new tab said on Thursday that its collaboration with Pfizer (PFE.N), opens new tab has not changed, when asked to comment on a report that ...